Vidyalakshmi Chandramohan

9PUBLICATIONS
45CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 19, 2026
Antigen-specific CD8 T cells accumulate and functionally reactivate in the bone marrow following brain infection.

|Oct 16, 2026
EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial.

|Apr 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma.

|Mar 20, 2024
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma.

Michael A Sun, Haipei Yao, Qing Yang

|Feb 08, 2023
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.

Scott Parker, Charlotte McDowall, Luis Sanchez-Perez

|May 31, 2019
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.

Vidyalakshmi Chandramohan, Xuhui Bao, Xin Yu

Pageof 2

Frequent Collaborators

3 joint publications

Smita K Nair

3 joint publications

David M Ashley

3 joint publications

Annick Desjardins

3 joint publications

Roger McLendon